Your browser doesn't support javascript.
loading
No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbidities.
Chen, Meng; Choo, Eugene; Yoo, Bongin; Raut, Pranil; Haselkorn, Tmirah; Pazwash, Hooman; Holweg, Cecile T J; Hudes, Golda.
Affiliation
  • Chen M; Southwest Asthma and Allergy Associates, Houston, Texas.
  • Choo E; University of California San Francisco, San Francisco, California.
  • Yoo B; Genentech, Inc., South San Francisco, California.
  • Raut P; Genentech, Inc., South San Francisco, California.
  • Haselkorn T; EpiMetrix, Inc., Los Altos, California.
  • Pazwash H; Genentech, Inc., South San Francisco, California.
  • Holweg CTJ; Genentech, Inc., South San Francisco, California. Electronic address: holweg.cecile@gene.com.
  • Hudes G; Albert Einstein College of Medicine, Bronx, New York.
Ann Allergy Asthma Immunol ; 126(6): 666-673, 2021 06.
Article in En | MEDLINE | ID: mdl-33465457
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Asthmatic Agents / Anti-Allergic Agents / Omalizumab / Hypersensitivity Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Asthmatic Agents / Anti-Allergic Agents / Omalizumab / Hypersensitivity Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication: